Evidence map›Paper›PMID 35877733›Full record

ReviewMarine drugs2022

Random Mutagenesis as a Promising Tool for Microalgal Strain Improvement towards Industrial Production.

Mafalda Trovão, Lisa M Schüler, Adriana Machado, Gabriel Bombo, Sofia Navalho, Ana Barros, Hugo Pereira, Joana Silva, Filomena Freitas, João Varela

Abstract readReview
In one paragraph

Review in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Response of aBiology · 2026
    Article
  5. Review
  6. Breeding Chlorophyll-Deficient Mutants ofBioengineering (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. Enhancing the Signature Rose Aroma ofFoods (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Genetic mutations enhance the production of Exotoxin A byExperimental and therapeutic medicine · 2025
    Article
  16. Article
  17. Article
  18. Marine drugs · 2025
    Review
  19. Review
  20. Progress and challenges in CRISPR/Cas applications in microalgae.Journal of microbiology (Seoul, Korea) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mafalda TrovãoAllmicroalgae Natural Products S.A., R&D Department, Rua 25 de Abril s/n, 2445-413 Pataias, Portugal.ORCID 0000-0002-9465-7681
Lisa M SchülerGreenCoLab-Associação Oceano Verde, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0003-0961-5397
Adriana MachadoAllmicroalgae Natural Products S.A., R&D Department, Rua 25 de Abril s/n, 2445-413 Pataias, Portugal.
Gabriel BomboGreenCoLab-Associação Oceano Verde, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
Sofia NavalhoGreenCoLab-Associação Oceano Verde, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0001-9380-4945
Ana BarrosAllmicroalgae Natural Products S.A., R&D Department, Rua 25 de Abril s/n, 2445-413 Pataias, Portugal.
Hugo PereiraGreenCoLab-Associação Oceano Verde, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
Joana SilvaAllmicroalgae Natural Products S.A., R&D Department, Rua 25 de Abril s/n, 2445-413 Pataias, Portugal.
Filomena FreitasAssociate Laboratory i4HB-Institute for Health and Bioeconomy, School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.ORCID 0000-0002-9430-4640
João VarelaGreenCoLab-Associação Oceano Verde, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0003-3101-693X

Funding

Fundação para a Ciência e Tecnologia LA/P/0101/2020Fundação para a Ciência e Tecnologia LA/P/0140/2020Fundação para a Ciência e Tecnologia UIDB/04326/2020Fundação para a Ciência e Tecnologia UIDB/04378/2020Fundação para a Ciência e Tecnologia UIDP/04326/2020Fundação para a Ciência e Tecnologia UIDP/04378/2020
6 · The paper itself

Abstract

Microalgae have become a promising novel and sustainable feedstock for meeting the rising demand for food and feed. However, microalgae-based products are currently hindered by high production costs. One major reason for this is that commonly cultivated wildtype strains do not possess the robustness and productivity required for successful industrial production. Several strain improvement technologies have been developed towards creating more stress tolerant and productive strains. While classical methods of forward genetics have been extensively used to determine gene function of randomly generated mutants, reverse genetics has been explored to generate specific mutations and target phenotypes. Site-directed mutagenesis can be accomplished by employing different gene editing tools, which enable the generation of tailor-made genotypes. Nevertheless, strategies promoting the selection of randomly generated mutants avoid the introduction of foreign genetic material. In this paper, we review different microalgal strain improvement approaches and their applications, with a primary focus on random mutagenesis. Current challenges hampering strain improvement, selection, and commercialization will be discussed. The combination of these approaches with high-throughput technologies, such as fluorescence-activated cell sorting, as tools to select the most promising mutants, will also be discussed.

Indexed as

MicroalgaeBiofuelsMutagenesisMutationBiofuelsadaptive laboratory evolutionfluorescence-activated cell sortinggenetic engineeringreverse and forward geneticsselection methods

Identifiers

PMID35877733
PMCPMC9318807

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.